Post-therapy stress symptoms after gynecologic brachytherapy in cervical cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, prospective observational study collects self-reported data to document psychological effects, including post-traumatic stress symptoms, in women treated with HDR or PDR uterovaginal brachytherapy for cervical cancer. Participants complete validated questionnaires in French, with follow-up to five years to observe persistence or changes in symptoms. The goal is to identify risk factors and inform potential psychological support strategies during and after treatment. No experimental interventions are involved beyond questionnaire assessments, and results may guide future care pathways.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Confirmed diagnosis of cervical cancer with an indication for High-dose rate (HDR) or pulse-dose rate (PDR) uterovaginal brachytherapy;
* Squamous cell carcinoma or other histological types;
* WHO ≤ 2;
* Ability to complete validated questionnaires in French;
* Informed consent to participate in the study;
* Patients over 18 years old

Exclusion Criteria:

* Inability to understand or respond to questionnaires due to a cognitive disorder, intellectual disability, language barrier, or psychiatric disorder that impairs judgment;
* Patient under juridic protection;
* Pregnant or breastfeeding woman

Where it's running

• Groupement Hospitalier Sud - Hopital Lyon Sud
  Pierre-Bénite, France Recruiting
• Icans
  Strasbourg, France Recruiting

Study contacts

• Principal investigator: George NOEL, MD, PhD — Icans, Cps
• Study coordinator: Valérie SARTORI
• Email: promotion-rc@icans.eu
• Phone: 368767223

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Enlonstobart with chemotherapy and radiotherapy for locally advanced cervical cancer

  This study tests whether adding Enlonstobart to standard chemotherapy and chemoradiotherapy helps patients with locally advanced cervical cancer by increasing response rates and monitoring safety.

  Recruiting at 2 sites Phase 4 Tianjin Medical University Cancer Institute and Hospital · Tianjin and 1 other locations · NCT07776821

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• Immunotherapy Plus Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer

  This trial tests whether adding immunotherapy and chemotherapy to carbon ion radiotherapy can help women with locally advanced cervical cancer live longer without the cancer growing.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07702838

• Dual PD1/CTLA4 immunotherapy with chemotherapy before surgery for locally advanced cervical cancer

  This study tests a combo of a PD1/CTLA4 bispecific antibody with standard chemotherapy to see if it can improve outcomes before surgery in women with locally advanced cervical cancer.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT07646301

• Radiomic MRI model to predict response to chemoradiotherapy in locally advanced cervical cancer

  This project tests whether MRI-based radiomic features can predict how women with locally advanced cervical cancer will respond to combined chemotherapy and radiation.

  Recruiting Centre Hospitalier Universitaire de Nīmes · Nîmes, Gard · NCT07305727

• Interactive video plus navigator to help Black women get cervical cancer screening

  This project will test whether an interactive video paired with an in-person navigator helps Black women who are overdue get cervical cancer screening more often than a standard educational video.

  Recruiting ISA Associates, Inc. · Washington D.C., District of Columbia and 1 other locations · NCT07011836

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.